Indeed Snapshot

Track Cardiovascular Systems reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 29th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 11.00 About a week 11.00 MEDIUM 10.00 FAVORABLE Aug 29th, 2022 11:49AM Aug 29th, 2022 11:49AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 28th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 11.00 About a week 11.00 MEDIUM 10.00 FAVORABLE Aug 28th, 2022 04:48AM Aug 28th, 2022 04:48AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 27th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 11.00 About a week 11.00 MEDIUM 10.00 FAVORABLE Aug 27th, 2022 04:08AM Aug 27th, 2022 04:08AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 25th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 11.00 About a week 11.00 MEDIUM 10.00 FAVORABLE Aug 25th, 2022 08:47AM Aug 25th, 2022 08:47AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 23rd, 2022 12:00AM Open Cardiovascular Systems, Inc. Health Care Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 23rd, 2022 10:41AM Aug 23rd, 2022 10:41AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 21st, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 21st, 2022 12:24PM Aug 21st, 2022 12:24PM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 20th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 20th, 2022 02:01PM Aug 20th, 2022 02:01PM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 19th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 19th, 2022 12:24PM Aug 19th, 2022 12:24PM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 18th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 18th, 2022 04:08AM Aug 18th, 2022 04:08AM Cardiovascular Systems Health Care Health Care Equipment & Services
nasdaq:csii https://www.indeed.com/cmp/cardiovascular-systems,-inc. Aug 17th, 2022 12:00AM Open Cardiovascular Systems, Inc. Pharmaceutical & Biotechnology Putting a new spin on your career Working at CSI means being a part of something greater than ourselves. We think big and move fast. From creating revolutionary technologies, to working with world class physicians and teams, we don’t simply work, we save lives. We have big company drive and small company vibe where your daily impact can be felt company-wide. If you are curious, ambitious and dedicated, you will love our community. Grow with us! Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary artery disease. Our primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications it presents for the millions who suffer from peripheral artery disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe and effective medical devices to help improve patient outcomes. We have developed patented orbital atherectomy systems (OAS) technology for both peripheral and coronary commercial applications. Our peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with other treatment alternatives. Our coronary product is a catheter-based platform designed to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions. The Coronary OAS design is similar to technology used in our Peripheral OAS, customized specifically for the coronary application. RRv1_100M_500M Saint Paul, MN 3.10 26.00 26.00 2.70 3.70 2.40 2.50 3.20 10.00 About a week 10.00 MEDIUM 10.00 FAVORABLE Aug 17th, 2022 09:47AM Aug 17th, 2022 09:47AM Cardiovascular Systems Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.